VISIT AIQ SOLUTIONS AT 2022 ASCO GENITOURINARY CANCERS SYMPOSIUM BOOTH #36

Post author By AIQ847llIovj
Post date October 24, 2021

Australian Privacy Policy AIQ's software has been cleared for clinical use under 510(k) K173444. For details, including the applicable Indications for Use, see: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K173444